EGFR and neoplasm: By functionalizing AuNPs with targeting agents, e.g., anti-EGFR antibodies, the tumor-specificity and contrast efficiency can be significantly enhanced, as demonstrated by [119] for head and neck squamous cell carcinoma in mice.